Investment Strategy
We are the UK’s most active investor in university spinouts
Championing breakthrough ideas
Proven Process
Every day, world-class research emerges from UK universities. Some of it has the power to reshape industries —but only if it can cross the gap between lab and market. Parkwalk exists to bridge that gap.
We back deeptech companies built on cutting-edge university IP, applying a clear, disciplined strategy to turn complex science into commercial success. Our approach turns breakthrough ideas into economic growth and improves lives worldwide, generating huge returns for our investors, UK plc, and broader society.
How we invest
Early-Stage Access
Our edge lies in where we operate.
Sitting at the heart of the UK’s university commercialisation ecosystem, we work closely with leading institutions across the country. These trusted relationships give us unique access to exceptional founders and world-class intellectual property, long before they reach the wider market.
Our expertise, knowledge and deal-flow pipeline helps high-potential ventures at Series A to Series C scale globally, and generates the potential for significant returns for investors. Rigorous due diligence and long-term thinking guiding every step.
What we focus on
Sectors
We back companies with the potential to change how the world works, as well as the resilience to get there. Our portfolio spans the most transformative areas of deeptech innovation. This targeted approach lets us build a diversified portfolio of high-growth businesses, each grounded in breakthrough university research and designed to scale.
FAQs
What is Parkwalk's investment strategy?
Parkwalk’s investment strategy focuses on backing university spinouts — high-growth companies built on breakthrough research from the UK’s leading academic institutions. We invest across deeptech sectors such as AI, quantum computing, cleantech, and digital health.
How does Parkwalk invest in UK university spinouts?
We work in close partnership with UK universities and their commercialisation teams to identify promising innovations early. Parkwalk invests from Seed to Series C, supporting companies as they scale and commercialise their technology globally.
At what stage does Parkwalk typically invest?
Parkwalk invests from Seed to Series C stages, supporting university spinouts as they evolve from early proof-of-concept through to commercial scale and international growth.
What kind of company qualifies for an EIS investment?
For a UK business to qualify for EIS it must have made its first commercial sale in the past 7 years. It should also have fewer than 250 employees and gross assets not exceeding £15m. Additionally, the company must operate solely within the UK and cannot be listed on the London Stock Exchange.
What makes Parkwalk's EIS funds different from other UK EIS funds?
Parkwalk stands apart through its exclusive focus on deeptech spinouts from leading UK universities. This gives investors exposure to defensible, research-driven companies with global potential — an approach few generalist funds can match.